| Literature DB >> 33446559 |
Katherine J Susa1, Shaun Rawson1, Andrew C Kruse2, Stephen C Blacklow2,3.
Abstract
Signaling through the CD19-CD81 co-receptor complex, in combination with the B cell receptor, is a critical determinant of B cell development and activation. It is unknown how CD81 engages CD19 to enable co-receptor function. Here, we report a 3.8-angstrom structure of the CD19-CD81 complex bound to a therapeutic antigen-binding fragment, determined by cryo-electron microscopy (cryo-EM). The structure includes both the extracellular domains and the transmembrane helices of the complex, revealing a contact interface between the ectodomains that drives complex formation. Upon binding to CD19, CD81 opens its ectodomain to expose a hydrophobic CD19-binding surface and reorganizes its transmembrane helices to occlude a cholesterol binding pocket present in the apoprotein. Our data reveal the structural basis for CD19-CD81 complex assembly, providing a foundation for rational design of therapies for B cell dysfunction.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33446559 PMCID: PMC8111558 DOI: 10.1126/science.abd9836
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728